{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:10:36Z","timestamp":1778217036649,"version":"3.51.4"},"reference-count":89,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Bladder cancer, particularly muscle-invasive bladder cancer, has become a major challenge in clinical treatment due to its high recurrence rate and therapeutic resistance. Traditional treatments\u2014including transurethral resection of bladder tumors, intravesical chemotherapy, and radical cystectomy\u2014exhibit significant limitations in drug delivery efficiency and anti-resistance efficacy, failing to achieve improved therapeutic outcomes. In recent years, smart, responsive, and multifunctional nanoplatforms have gained attention for their precise responsiveness to the tumor microenvironment, enabling targeted and controlled drug release, as well as multimodal combination therapy with promising clinical applications. This review examines the design principles of smart, responsive nanoparticles and their specific applications in the integrated diagnosis and treatment of bladder cancer, exploring their role and advantages in overcoming therapeutic resistance mechanisms. Additionally, it analyzes engineering challenges and safety concerns encountered during the transition from laboratory research to clinical translation, proposing future development strategies and countermeasures. The review aims to provide systematic theoretical support and practical guidance for innovative developments in bladder cancer nanomedicine, thereby advancing the field of precision medicine.<\/jats:p>","DOI":"10.3389\/fonc.2026.1803259","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:33:23Z","timestamp":1778214803000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Application and challenges of smart responsive multifunctional nanoplatforms in integrated diagnosis and treatment of bladder cancer and overcoming therapeutic resistance"],"prefix":"10.3389","volume":"16","author":[{"given":"Long","family":"Chen","sequence":"first","affiliation":[{"name":"Tongliao Clinical Medicao College, Inner Mongolia Medical University","place":["Hohhot, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gai","family":"Hang","sequence":"additional","affiliation":[{"name":"Department of Urinary surgery, Tongliao People\u2019s Hospital","place":["Tongliao, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Urinary surgery, Tongliao People\u2019s Hospital","place":["Tongliao, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Ren","sequence":"additional","affiliation":[{"name":"Tongliao Sixth People\u2019s Hospital","place":["Tongliao, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Urinary surgery, Tongliao People\u2019s Hospital","place":["Tongliao, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/s41419-025-08221-8","article-title":"MET signaling drives acquired resistance to erdafitinib in muscle-invasive bladder cancer cells","volume":"16","author":"Makabe","year":"2025","journal-title":"Cell Death Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-21-0725","article-title":"Cigarette smoke containing acrolein contributes to cisplatin resistance in human bladder cancers through the regulation of HER2 pathway or FGFR3 pathway","volume":"21","author":"Hong","year":"2022","journal-title":"Mol Cancer Ther"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2025.09.023","article-title":"Molecular subtyping of advanced bladder cancer patients and patient-derived organoids based on a 3-marker immunohistochemistry approach to evaluate chemotherapy sensitivity","volume":"44","author":"Viergever","year":"2026","journal-title":"Urol Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15010211","article-title":"The progress of chitosan-based nanoparticles for intravesical bladder cancer treatment","volume":"15","author":"Yu","year":"2023","journal-title":"Pharmaceutics"},{"key":"B5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2147\/IJN.S280034","article-title":"DPPG2-based thermosensitive liposomes with encapsulated doxorubicin combined with hyperthermia lead to higher doxorubicin concentrations in the bladder compared to conventional application in pigs: a rationale for the treatment of muscle-invasive bladder cancer","volume":"16","author":"van Valenberg","year":"2021","journal-title":"Int J Nanomedicine"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.102585","article-title":"Nanoparticle-based drug delivery systems in urologic oncology: From targeted therapy to precision theranostics","volume":"35","author":"Ma","year":"2025","journal-title":"Mater Today Bio"},{"key":"B7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s40820-025-01717-0","article-title":"Multifunctional and scalable nanoparticles for bimodal image-guided phototherapy in bladder cancer treatment","volume":"17","author":"Tang","year":"2025","journal-title":"Nano Micro Lett"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1039\/d5nr00374a","article-title":"Synergistic nanoplatform of M1 macrophage-derived extracellular vesicles and MoS2 for tumor-targeted photoimmunotherapy in bladder cancer","volume":"17","author":"Chuang","year":"2025","journal-title":"Nanoscale"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123126","article-title":"Photochemical bomb: Precision nuclear targeting to activate cGAS-STING pathway for enhanced bladder cancer immunotherapy","volume":"318","author":"Feng","year":"2025","journal-title":"Biomaterials"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000001528","article-title":"Codelivery of ERCC2 small interfering RNA and cisplatin with macrophage-derived mimetic nanovesicles for enhanced bladder cancer treatment","volume":"34","author":"Zhou","year":"2023","journal-title":"Anticancer Drugs"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.1c00448","article-title":"Immunotherapy strategy targeting programmed cell death ligand 1 and CD73 with macrophage-derived mimetic nanovesicles to treat bladder cancer","volume":"18","author":"Zhou","year":"2021","journal-title":"Mol Pharm"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.11477\/ganntokagakuryoho.52.3_217","article-title":"Bladder preservation therapy for bladder cancer","volume":"52","author":"Tanaka","year":"2025","journal-title":"Gan to Kagaku Ryoho"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1001\/jama.2020.17601","article-title":"Bladder cancer","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00212-24","article-title":"BCG therapy in bladder cancer and its tumor microenvironment interactions","volume":"38","author":"Jian","year":"2025","journal-title":"Clin Microbiol Rev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd1346","article-title":"Dendritic cell targeting with Fc-enhanced CD40 antibody agonists induces durable antitumor immunity in humanized mouse models of bladder cancer","volume":"13","author":"Garris","year":"2021","journal-title":"Sci Transl Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.urolonc.2021.10.012","article-title":"Bladder-sparing combination treatments for muscle-invasive bladder cancer: A plea for standardized assessment and definition of clinical trials endpoints","volume":"40","author":"Basile","year":"2022","journal-title":"Urol Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112152-20240602-00231","article-title":"Expert consensus of multi-disciplinary collaboration on bladder-preserving treatment for bladder cancer in China (2024 edition)","volume":"46","year":"2024","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2020.1736565","article-title":"Bladder-sparing treatment options in localized muscle-invasive bladder cancer","volume":"20","author":"Nason","year":"2020","journal-title":"Expert Rev Anticancer Ther"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/MOU.0000000000001220","article-title":"Bladder sparing options for muscle-invasive bladder cancer","volume":"34","author":"Laukhtina","year":"2024","journal-title":"Curr Opin Urol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2024.100866","article-title":"Bladder-preserving radiation therapy for patients with locally advanced and node-positive bladder cancer","volume":"49","author":"Carriere","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000031635","article-title":"Metformin and bladder cancer: Drug repurposing as a potential tool for novel therapy: A review","volume":"101","author":"Feng","year":"2022","journal-title":"Med (Baltimore)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11934-025-01278-0","article-title":"Re-appraisal of standard of care imaging to identify predictors of treatment outcomes among patients with bladder and upper tract urothelial cancers","volume":"26","author":"Harper","year":"2025","journal-title":"Curr Urol Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.eururo.2025.03.017","article-title":"Bladder preservation strategies in muscle-invasive bladder cancer: Recommendations from the International Bladder Cancer Group","volume":"89","author":"Gupta","year":"2026","journal-title":"Eur Urol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15122724","article-title":"Local drug delivery in bladder cancer: Advances of nano\/micro\/macro-scale drug delivery systems","volume":"15","author":"Marchenko","year":"2023","journal-title":"Pharmaceutics"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1177\/03915603251319133","article-title":"TAR-200: Investigational intravesical drug delivery system for bladder cancer","volume":"92","author":"Munavvir","year":"2025","journal-title":"Urologia"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2024.07.003","article-title":"Strategies for intravesical drug delivery: From bladder physiological barriers and potential transport mechanisms","volume":"14","author":"Li","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.778973","article-title":"Functional nanomedicines for targeted therapy of bladder cancer","volume":"12","author":"Tang","year":"2021","journal-title":"Front Pharmacol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.21037\/tau-2025-483","article-title":"Pharmacotherapy for bladder spasm and irritative lower urinary tract symptoms associated with intravesical therapy for bladder cancer: a review of available evidence","volume":"14","author":"Albakr","year":"2025","journal-title":"Transl Androl Urol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jconrel.2020.03.028","article-title":"Mucoadhesive nanoparticles based on ROS activated gambogic acid prodrug for safe and efficient intravesical instillation chemotherapy of bladder cancer","volume":"324","author":"Xu","year":"2020","journal-title":"J Control Release"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.7150\/jca.100846","article-title":"Ultrasound irradiation in the presence of microbubbles may enhance the antitumor effect of chemotherapeutic agents against bladder cancer","volume":"16","author":"Suzuki","year":"2025","journal-title":"J Cancer"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2020.110832","article-title":"Poly(amidoamine)-modified mesoporous silica nanoparticles as a mucoadhesive drug delivery system for potential bladder cancer therapy","volume":"189","author":"Wang","year":"2020","journal-title":"Colloids Surf B Biointerfaces"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.3c09564","article-title":"Hyaluronic acid-conjugated fluorescent probe-shielded polydopamine nanomedicines for targeted imaging and chemotherapy of bladder cancer","volume":"15","author":"Qiu","year":"2023","journal-title":"ACS Appl Mater Interfaces"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2022.102600","article-title":"Tumor-targeting albumin nanoparticles as an efficacious drug delivery system and potential diagnostic tool in non-muscle-invasive bladder cancer therapy","volume":"46","author":"Mullapudi","year":"2022","journal-title":"Nanomedicine"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1080\/03639045.2025.2504440","article-title":"Albumin-based nanoparticles: a potential and emerging oral drug delivery system","volume":"51","author":"Sun","year":"2025","journal-title":"Drug Dev Ind Pharm"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1021\/acsabm.4c01167","article-title":"Dual thermo- and pH-responsive polymer nanoparticle assemblies for potential stimuli-controlled drug delivery","volume":"8","author":"Pytl\u00edkov\u00e1","year":"2025","journal-title":"ACS Appl Bio Mater"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/nano15020133","article-title":"Doxorubicin-conjugated nanoparticles for potential use as drug delivery systems","volume":"15","author":"Imantay","year":"2025","journal-title":"Nanomaterials (Basel)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/bios12100796","article-title":"State-of-the-art advances of nanomedicine for diagnosis and treatment of bladder cancer","volume":"12","author":"Kong","year":"2022","journal-title":"Biosens-Basel"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.2c00540","article-title":"A lysosome-targeting self-condensation prodrug-nanoplatform system for addressing drug resistance of cancer","volume":"22","author":"Hou","year":"2022","journal-title":"Nano Lett"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202310522","article-title":"A \u201cone arrow three eagle\u201d strategy to improve CM-272 primed bladder cancer immunotherapy","volume":"36","author":"Liu","year":"2024","journal-title":"Adv Mater"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2025.114954","article-title":"Bimetallic nanozyme-mediated dual ferroptosis\/cuproptosis synergy potentiates immunotherapy in bladder cancer","volume":"255","author":"Chen","year":"2025","journal-title":"Colloids Surf B Biointerfaces"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2020.102192","article-title":"CD133 antibody targeted delivery of gold nanostars loading IR820 and docetaxel for multimodal imaging and near-infrared photodynamic\/photothermal\/chemotherapy against castration resistant prostate cancer","volume":"27","author":"Tan","year":"2020","journal-title":"Nanomedicine"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1039\/d2bm00803c","article-title":"A multifunctional theranostics nanosystem featuring self-assembly of alcohol-abuse drug and photosensitizers for synergistic cancer therapy","volume":"10","author":"Wu","year":"2022","journal-title":"Biomater Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9100993","article-title":"Carbosilane dendrimers loaded with siRNA targeting Nrf2 as a tool to overcome cisplatin chemoresistance in bladder cancer cells","volume":"9","author":"Ambrosio","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcis.2024.11.003","article-title":"Nuclear-targeted smart nanoplatforms featuring double-shell hollow mesoporous copper sulfide coated with manganese dioxide synergistically potentiate chemotherapy and immunotherapy in hepatocellular carcinoma cells","volume":"680","author":"Li","year":"2025","journal-title":"J Colloid Interface Sci"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1021\/acs.bioconjchem.1c00321","article-title":"Dual blood-brain barrier-glioma targeting peptide-poly(levodopamine) hybrid nanoplatforms as potential near infrared phototheranostic agents in glioblastoma","volume":"32","author":"Dube","year":"2021","journal-title":"Bioconjug Chem"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.01.024","article-title":"Chemo-photothermal nanoplatform with diselenide as the key for ferroptosis in colorectal cancer","volume":"366","author":"Deng","year":"2024","journal-title":"J Control Release"},{"key":"B47","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1186\/s12951-025-03796-y","article-title":"Targeting cancer stem-like cells via cholesterol modulation and ferroptosis induction using a multifunctional nanoplatform to overcome drug resistance","volume":"23","author":"Ye","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"23138","DOI":"10.1038\/s41598-025-06965-z","article-title":"mTOR pathway targeted inhibition via rapamycin-loaded PLGA nanoparticles for enhanced bladder cancer therapy","volume":"15","author":"El-Hefnawy","year":"2025","journal-title":"Sci Rep"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1438297","article-title":"Clinical insights into nanomedicine and biosafety: advanced therapeutic approaches for common urological cancers","volume":"14","author":"Fattahi","year":"2024","journal-title":"Front Oncol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.7150\/thno.45358","article-title":"Synergy of tumor microenvironment remodeling and autophagy inhibition to sensitize radiation for bladder cancer treatment","volume":"10","author":"Lin","year":"2020","journal-title":"Theranostics"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2023.100555","article-title":"Oxygen-carrying nanoplatform to reprogram tumor immunosuppressive microenvironment and enhance photothermal-immunotherapy","volume":"19","author":"Huang","year":"2023","journal-title":"Mater Today Bio"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.1c03277","article-title":"Tumor microenvironment-responsive theranostic nanoplatform for guided molecular dynamic\/photodynamic synergistic therapy","volume":"13","author":"Zhang","year":"2021","journal-title":"ACS Appl Mater Interfaces"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1039\/d2tb00337f","article-title":"Tumor microenvironment-regulated nanoplatforms for the inhibition of tumor growth and metastasis in chemo-immunotherapy","volume":"10","author":"Yu","year":"2022","journal-title":"J Mater Chem B"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202509075","article-title":"Innovative DCZCMC platform: Dual regulation of cholesterol dynamics and the cGAS\/STING pathway activation to combat drug resistance in tumor therapy","volume":"21","author":"Wang","year":"2025","journal-title":"Small"},{"key":"B55","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s13046-024-03146-0","article-title":"Synergistic intravesical instillation for bladder cancer: CRISPR-Cas13a and fenbendazole combination therapy","volume":"43","author":"Liang","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043812","article-title":"Nanoparticle-based techniques for bladder cancer imaging: A review","volume":"24","author":"Boschi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1021\/acsbiomaterials.5c00960","article-title":"Engineering Schottky junction nanocatalysts for enhanced charge carrier separation and synergistic PDT\/PTT\/CDT in bladder cancer therapy","volume":"11","author":"Xu","year":"2025","journal-title":"ACS Biomater Sci Eng"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.7150\/thno.99040","article-title":"Platelets camouflaged nanovehicle improved bladder cancer immunotherapy by triggering pyroptosis","volume":"14","author":"Tian","year":"2024","journal-title":"Theranostics"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.2174\/1389201023666220413091055","article-title":"Biocompatible nanomaterials for burns","volume":"23","author":"Handa","year":"2022","journal-title":"Curr Pharm Bio\/Technol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2021.118646","article-title":"Biocidal and biocompatible hybrid nanomaterials from biomolecule chitosan, alginate and ZnO","volume":"274","author":"Karthikeyan","year":"2021","journal-title":"Carbohydr Polym"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101482","article-title":"Progress on carbon dots and hydroxyapatite based biocompatible luminescent nanomaterials for cancer theranostics","volume":"24","author":"Sengar","year":"2022","journal-title":"Transl Oncol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158183","article-title":"Nanodiamonds as possible tools for improved management of bladder cancer and bacterial cystitis","volume":"23","author":"Zupan\u010di\u010d","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.117027","article-title":"Graphene oxide nanoarchitectures in cancer therapy: Drug and gene delivery, phototherapy, immunotherapy, and vaccine development","volume":"237","author":"Sadeghi","year":"2023","journal-title":"Environ Res"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1647988","article-title":"Advances in the study of reversing tumor drug resistance by targeting cancer-associated fibroblasts with nanomaterials","volume":"16","author":"Gao","year":"2025","journal-title":"Front Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"042001","DOI":"10.1088\/1748-605X\/abe5fa","article-title":"Biocompatibility of nanomaterials and their immunological properties","volume":"16","author":"Kyriakides","year":"2021","journal-title":"BioMed Mater"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioelechem.2022.108286","article-title":"Evolution of nanomaterial electrochemiluminescence luminophores towards biocompatible materials","volume":"149","author":"O\u2019Connor","year":"2022","journal-title":"Bioelectrochemistry"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.0c00834","article-title":"Graphene-wrapped copper nanoparticles: An antimicrobial and biocompatible nanomaterial with valuable properties for medical uses","volume":"5","author":"Vasilopoulos","year":"2020","journal-title":"ACS Omega"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2020.589957","article-title":"Application of functional biocompatible nanomaterials to improve curcumin bioavailability","volume":"8","author":"Li","year":"2020","journal-title":"Front Chem"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.4c15600","article-title":"De novo design of biocompatible nanomaterials using quasi-SMILES and recurrent neural networks","volume":"16","author":"He","year":"2024","journal-title":"ACS Appl Mater Interfaces"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2024.100964","article-title":"Progress and application of intelligent nanomedicine in urinary system tumors","volume":"14","author":"Xiao","year":"2024","journal-title":"J Pharm Anal"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201906783","article-title":"Realizing cancer precision medicine by integrating systems biology and nanomaterial engineering","volume":"32","author":"Joo","year":"2020","journal-title":"Adv Mater"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2021.02.030","article-title":"Recent advances of redox-responsive nanoplatforms for tumor theranostics","volume":"332","author":"Chen","year":"2021","journal-title":"J Control Release"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-024-03559-w","article-title":"Advancements in nanotheranostics for glioma therapy","volume":"398","author":"Sahoo","year":"2025","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1080\/03639045.2025.2569572","article-title":"Nanocarriers as drug delivery system for chemotherapeutic agents: from inception to clinical implementation","volume":"51","author":"Zubair","year":"2025","journal-title":"Drug Dev Ind Pharm"},{"key":"B75","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12943-025-02357-z","article-title":"Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery","volume":"24","author":"Sabit","year":"2025","journal-title":"Mol Cancer"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.70027","article-title":"Machine learning and artificial intelligence in nanomedicine","volume":"17","author":"Chou","year":"2025","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114194","article-title":"Artificial intelligence to bring nanomedicine to life","volume":"184","author":"Serov","year":"2022","journal-title":"Adv Drug Delivery Rev"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201901862","article-title":"Artificial intelligence and machine learning in computational nanotoxicology: unlocking and empowering nanomedicine","volume":"9","author":"Singh","year":"2020","journal-title":"Adv Healthc Mater"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1039\/c8nh00233a","article-title":"Artificial intelligence in nanomedicine","volume":"4","author":"Ho","year":"2019","journal-title":"Nanoscale Horiz"},{"key":"B80","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.semcancer.2023.01.005","article-title":"Artificial intelligence aids in development of nanomedicines for cancer management","volume":"89","author":"Tan","year":"2023","journal-title":"Semin Cancer Biol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2025.2502022","article-title":"Explicating the transformative role of artificial intelligence in designing targeted nanomedicine","volume":"22","author":"Akhtar","year":"2025","journal-title":"Expert Opin Drug Delivery"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2023.2167978","article-title":"Re-envisioning the design of nanomedicines: harnessing automation and artificial intelligence","volume":"20","author":"Zaslavsky","year":"2023","journal-title":"Expert Opin Drug Delivery"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3390\/cells14010014","article-title":"Detection of human bladder epithelial cancerous cells with atomic force microscopy and machine learning","volume":"14","author":"Petrov","year":"2024","journal-title":"Cells"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1039\/d4nr01832j","article-title":"Application of artificial intelligence in cancer diagnosis and tumor nanomedicine","volume":"16","author":"Wang","year":"2024","journal-title":"Nanoscale"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1093\/jpp\/rgaf113","article-title":"Artificial intelligence-enabled nanomedicine: enhancing drug design and predictive modeling in pharmaceutics","volume":"75","author":"Sarhan","year":"2025","journal-title":"J Pharm Pharmacol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-024-03798-9","article-title":"The role of artificial intelligence and machine learning in accelerating the discovery and development of nanomedicine","volume":"41","author":"Agrahari","year":"2024","journal-title":"Pharm Res"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1129771","article-title":"Bioengineered bacterial outer membrane vesicles encapsulated Polybia-mastoparan I fusion peptide as a promising nanoplatform for bladder cancer immune-modulatory chemotherapy","volume":"14","author":"Ren","year":"2023","journal-title":"Front Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10353","article-title":"(Nano)platforms in bladder cancer therapy: Challenges and opportunities","volume":"8","author":"Ashrafizadeh","year":"2023","journal-title":"Bioeng Transl Med"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122145","article-title":"A transformable nanoplatform with multiple therapeutic and immunostimulatory properties for treatment of advanced cancers","volume":"299","author":"Xue","year":"2023","journal-title":"Biomaterials"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1803259\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:33:31Z","timestamp":1778214811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1803259\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":89,"alternative-id":["10.3389\/fonc.2026.1803259"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1803259","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"article-number":"1803259"}}